Press Releases.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
September 27, 2018
-
September 26, 2018Hepatitis B virus Lead Compound Demonstrates Compelling Data in Preclinical Studies
-
August 09, 2018Corporate Restructuring and Pipeline Focus Expected to Extend Cash Runway
-
July 05, 2018Efforts Aimed at Extending Cash Runway to mid-2019
-
May 10, 2018Two pre-clinical programs advance towards clinical candidates
-
May 03, 2018Conference Call and Webcast to Follow
-
May 01, 2018Initial safety and pharmacokinetic results from single ascending dose study support advancement
-
April 17, 2018
-
March 20, 2018
-
March 07, 2018Full enrollment of RG-012 studies anticipated in 2H 2018
-
February 28, 2018Conference Call and Webcast to Follow
-
November 07, 2017Conference Call Today at 5:00 p.m. ET
-
October 31, 2017Conference Call and Webcast to Follow
-
August 30, 2017
-
August 01, 2017Completed Public Offering Raising $46 Million in Gross Proceeds
-
July 25, 2017Conference Call and Webcast to Follow
-
June 12, 2017Phase II RG-012 HERA and Renal Biopsy studies for Alport syndrome move forward
-
June 01, 2017
-
May 04, 2017Company to Restructure Operations Accompanied by a Workforce Reduction
-
April 27, 2017Conference Call and Webcast to Follow
March 02, 2017RG-012 development program to include a separate biopsy study, which may provide earlier POC- February 23, 2017Conference Call and Webcast to Follow
- February 16, 2017Published results from preclinical studies show inhibition of miR-17 increased survival and reduced disease burden in mice
- January 27, 2017FDA requests longer-term follow-up data from ongoing studies
- November 01, 2016Conference Call Today at 5:00 p.m. ET
- October 25, 2016Conference Call and Webcast to Follow
- August 02, 2016Conference Call Today at 5:00 p.m. ET
- July 27, 2016On Track to Deliver Follow-up Results from On-going RG-101 Studies
- July 26, 2016Conference Call and Webcast to Follow
- June 27, 2016Timelines of On-going Studies are not Expected to be Impacted
- June 07, 2016- Results Demonstrate First Successful Shortened 4-week Treatment Regimen to Date -
